搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
16 小时
Parkinson’s Paradox: New Study Reveals Unexpected Dopamine-Tremor Connection
Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...
PharmTech
1 天
European Biotechs Unlocking Parkinson’s Disease
Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...
2 天
Scientists Identify Protein That Could Alleviate Parkinson’s Disease
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
Science Daily
1 天
Parkinson's Research News
Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...
News Medical on MSN
6 小时
Wearables and machine learning predict five-year fall risk in Parkinson’s patients
By Dr. Chinta Sidharthan Sensor data from wearable devices analyzed over five years reveals walking and posture differences ...
sciencex
6 天
World-first clinical trial hopes to stop Parkinson's in its tracks
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Yahoo Finance
4 天
BioArctic doses first subject in Parkinson’s disease therapy trial
Exidavnemab is being developed as a potential disease-modifying treatment, aiming to halt or slow the progression of ...
1 天
AbbVie Says Phase 3 TEMPO-2 Study Of Tavapadon In Early Parkinson's Disease Met Main Goal
Monday said Phase 3 TEMPO-2 study evaluating tavapadon in early Parkinson's disease met its primary goal. In the ...
8 天
A Denver artist and his visual journey through Parkinson’s Disease
When Denver artist Tim McKay was diagnosed with Parkinson’s disease last year, he made a quick decision: He would document ...
precisionmedicineonline
1 天
BioArctic Doses First Parkinson's Patient in Trial of Alpha-Synuclein-Targeting Drug
Exidavnemab is a monoclonal antibody designed to eliminate aggregated clumps of the protein biomarker and slow progression of Parkinson's disease.
precisionmedicineonline
5 天
Gain Therapeutics to Start Testing GCase-Targeted Drug in Patients with GBA1, Sporadic ...
The company is hoping to show GT-02287 can slow Parkinson's progression by restoring function of GCase, an enzyme encoded by ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈